Pregabalin

Product NDC: 71610-331
11-digit product format: 716100331
Labeler code: 71610
Product ID: 71610-331_49d5064f-654b-4a6b-be12-e11523738b04
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: PREGABALIN
Dosage form: CAPSULE
Route: ORAL
Labeler: Aphena Pharma Solutions - Tennessee, LLC
Application: ANDA208677
Marketing category: ANDA
Marketing start: 2019-07-19
Marketing end: 0000-00-00
Substance: PREGABALIN
Active strength: 225 mg/1
DEA schedule: CV
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	71610-331		I	Inactivated by FDA		2026-10-05
excluded package	package	71610-331	71610-331-53	I	Inactivated by FDA		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 18 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	71610-331-53	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	71610-331-53	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	71610-331-53	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	71610-331-53	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	71610-331-53	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	71610-331-53	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	71610-331-53	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	71610-331-53	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	71610-331-53	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 8 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A208677-001	PREGABALIN	PREGABALIN	25MG	CAPSULE / ORAL	AB	2019-07-19
A208677-002	PREGABALIN	PREGABALIN	50MG	CAPSULE / ORAL	AB	2019-07-19
A208677-003	PREGABALIN	PREGABALIN	75MG	CAPSULE / ORAL	AB	2019-07-19
A208677-004	PREGABALIN	PREGABALIN	100MG	CAPSULE / ORAL	AB	2019-07-19
A208677-005	PREGABALIN	PREGABALIN	150MG	CAPSULE / ORAL	AB	2019-07-19
A208677-006	PREGABALIN	PREGABALIN	200MG	CAPSULE / ORAL	AB	2019-07-19
A208677-007	PREGABALIN	PREGABALIN	225MG	CAPSULE / ORAL	AB	2019-07-19
A208677-008	PREGABALIN	PREGABALIN	300MG	CAPSULE / ORAL	AB	2019-07-19

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 8 matching rows.

Application-product, TE code table
Application-product	TE code
A208677-001	AB
A208677-002	AB
A208677-003	AB
A208677-004	AB
A208677-005	AB
A208677-006	AB
A208677-007	AB
A208677-008	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 9 · 336 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A208677-001	PREGABALIN	25MG	CAPSULE / ORAL	AB	2019-07-19	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A208677-002	PREGABALIN	50MG	CAPSULE / ORAL	AB	2019-07-19	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A208677-003	PREGABALIN	75MG	CAPSULE / ORAL	AB	2019-07-19	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A208677-004	PREGABALIN	100MG	CAPSULE / ORAL	AB	2019-07-19	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A208677-005	PREGABALIN	150MG	CAPSULE / ORAL	AB	2019-07-19	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A208677-006	PREGABALIN	200MG	CAPSULE / ORAL	AB	2019-07-19	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A208677-007	PREGABALIN	225MG	CAPSULE / ORAL	AB	2019-07-19	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A208677-008	PREGABALIN	300MG	CAPSULE / ORAL	AB	2019-07-19	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A208677-001	PREGABALIN	25MG	CAPSULE / ORAL	AB	2019-07-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A208677-002	PREGABALIN	50MG	CAPSULE / ORAL	AB	2019-07-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A208677-003	PREGABALIN	75MG	CAPSULE / ORAL	AB	2019-07-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A208677-004	PREGABALIN	100MG	CAPSULE / ORAL	AB	2019-07-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A208677-005	PREGABALIN	150MG	CAPSULE / ORAL	AB	2019-07-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A208677-006	PREGABALIN	200MG	CAPSULE / ORAL	AB	2019-07-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A208677-007	PREGABALIN	225MG	CAPSULE / ORAL	AB	2019-07-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A208677-008	PREGABALIN	300MG	CAPSULE / ORAL	AB	2019-07-19	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A208677-001	PREGABALIN	25MG	CAPSULE / ORAL	AB	2019-07-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A208677-002	PREGABALIN	50MG	CAPSULE / ORAL	AB	2019-07-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A208677-003	PREGABALIN	75MG	CAPSULE / ORAL	AB	2019-07-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A208677-004	PREGABALIN	100MG	CAPSULE / ORAL	AB	2019-07-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A208677-005	PREGABALIN	150MG	CAPSULE / ORAL	AB	2019-07-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A208677-006	PREGABALIN	200MG	CAPSULE / ORAL	AB	2019-07-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A208677-007	PREGABALIN	225MG	CAPSULE / ORAL	AB	2019-07-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A208677-008	PREGABALIN	300MG	CAPSULE / ORAL	AB	2019-07-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208677-001	PREGABALIN	25MG	CAPSULE / ORAL	AB	2019-07-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208677-002	PREGABALIN	50MG	CAPSULE / ORAL	AB	2019-07-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208677-003	PREGABALIN	75MG	CAPSULE / ORAL	AB	2019-07-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208677-004	PREGABALIN	100MG	CAPSULE / ORAL	AB	2019-07-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208677-005	PREGABALIN	150MG	CAPSULE / ORAL	AB	2019-07-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208677-006	PREGABALIN	200MG	CAPSULE / ORAL	AB	2019-07-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208677-007	PREGABALIN	225MG	CAPSULE / ORAL	AB	2019-07-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208677-008	PREGABALIN	300MG	CAPSULE / ORAL	AB	2019-07-19	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A208677-001	PREGABALIN	25MG	CAPSULE / ORAL	AB	2019-07-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A208677-002	PREGABALIN	50MG	CAPSULE / ORAL	AB	2019-07-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A208677-003	PREGABALIN	75MG	CAPSULE / ORAL	AB	2019-07-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A208677-004	PREGABALIN	100MG	CAPSULE / ORAL	AB	2019-07-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A208677-005	PREGABALIN	150MG	CAPSULE / ORAL	AB	2019-07-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A208677-006	PREGABALIN	200MG	CAPSULE / ORAL	AB	2019-07-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A208677-007	PREGABALIN	225MG	CAPSULE / ORAL	AB	2019-07-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A208677-008	PREGABALIN	300MG	CAPSULE / ORAL	AB	2019-07-19	`6a471c1ec25d…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 9 · 336 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	A208677-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A208677-002	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A208677-003	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A208677-004	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A208677-005	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A208677-006	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A208677-007	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A208677-008	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A208677-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A208677-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A208677-003	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A208677-004	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A208677-005	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A208677-006	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A208677-007	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A208677-008	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A208677-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A208677-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A208677-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A208677-004	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A208677-005	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A208677-006	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A208677-007	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A208677-008	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208677-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208677-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208677-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208677-004	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208677-005	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208677-006	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208677-007	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208677-008	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A208677-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A208677-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A208677-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A208677-004	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A208677-005	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A208677-006	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A208677-007	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A208677-008	AB	1	`6a471c1ec25d…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
441d8579-bd15-4585-93f4-9de3db2d851d	Product name	4	20251114
004d1029-ec13-fc89-74f4-3907cf5b6602	Product name	2	20140523

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
71610-331-53	2025-01-30	C162847	48780-1	f386c649-fba2-0266-e053-dadaa90a7c1a	These highlights do not include all the information needed to use PREGABALIN CAPSULES safely and effectively. See full prescribing information for PREGABALIN CAPSULES. PREGABALIN capsules, for oral use CV Initial U.S. Approval: 2004 Pediatric use information is approved for Pfizer's LYRICA (pregabalin) Capsules and Oral Solution products. However, due to Pfizer's marketing exclusivity rights, this drug product is not labeled with pediatric information.

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
71610-331-53	Pregabalin	60 in 1 BOTTLE	CAPSULE	60		1

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
71610-331-53	EA - Each	71610-331	d7e92f93-0371-42d2-a8ce-87307ee48fad	1	2019-10-07

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
71610-331	PREGABALIN CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	1	Legacy NDC, 1 package rows	20190911_f33a9245-8a54-4d1c-8fbd-e00194fa9c93.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 3 of 5 · 87 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Pregabalin	PREGABALIN	Aphena Pharma Solutions - Tennessee, LLC	3f002a7f-e632-e58f-e063-6394a90abce8	2025-09-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208677 application number: ANDA208677
Pregabalin	PREGABALIN	Aphena Pharma Solutions - Tennessee, LLC	3f00c179-336d-e534-e063-6294a90a9141	2025-09-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208677 application number: ANDA208677
Pregabalin	PREGABALIN	Preferred Pharmaceuticals, Inc.	8ac0689e-47a3-44d7-bf98-a919c302726d	2025-09-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208677 application number: ANDA208677
Pregabalin	PREGABALIN	Preferred Pharmaceuticals, Inc.	25345672-1368-4e3a-95b2-ca45fe120294	2025-09-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208677 application number: ANDA208677
Pregabalin	PREGABALIN	Aphena Pharma Solutions - Tennessee, LLC	3e9cfeb9-1e2b-ea79-e063-6394a90a67b1	2025-09-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208677 application number: ANDA208677
Pregabalin	PREGABALIN	Preferred Pharmaceuticals, Inc.	ceedde96-fdaf-4708-9ca1-e48e052cde75	2025-09-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208677 application number: ANDA208677
Pregabalin	PREGABALIN	Preferred Pharmaceuticals, Inc.	1760ccdc-46f7-4182-a563-96b13212cb7e	2025-09-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208677 application number: ANDA208677
Pregabalin	PREGABALIN	Preferred Pharmaceuticals, Inc.	3dbfd868-8408-4514-ba1c-04a5d095c16a	2025-09-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208677 application number: ANDA208677
Pregabalin	PREGABALIN	Aphena Pharma Solutions - Tennessee, LLC	31e7caf6-0a8b-f343-e063-6294a90ad729	2025-09-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208677 application number: ANDA208677
Pregabalin	PREGABALIN	Aphena Pharma Solutions - Tennessee, LLC	3c6daa12-5284-d9f1-e063-6294a90ae060	2025-08-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208677 application number: ANDA208677
Pregabalin	PREGABALIN	Aphena Pharma Solutions - Tennessee, LLC	3ab4efb3-1ae5-2504-e063-6294a90a6d1d	2025-07-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208677 application number: ANDA208677
Pregabalin	PREGABALIN	Aphena Pharma Solutions - Tennessee, LLC	3ab57054-02c2-5e28-e063-6294a90a71ab	2025-07-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208677 application number: ANDA208677
Pregabalin	PREGABALIN	Aphena Pharma Solutions - Tennessee, LLC	3a124f59-38c2-7280-e063-6394a90a43b4	2025-07-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208677 application number: ANDA208677
Pregabalin	PREGABALIN	Aphena Pharma Solutions - Tennessee, LLC	3a1374f4-79dd-ebbc-e063-6394a90a53b0	2025-07-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208677 application number: ANDA208677
PREGABALIN	PREGABALIN	Direct_Rx	8efb9652-86b9-4cb5-e053-2995a90adac0	2025-01-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208677 application number: ANDA208677
PREGABALIN	PREGABALIN	Direct_Rx	8ee9e08f-cf87-599c-e053-2995a90a563c	2025-01-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208677 application number: ANDA208677
PREGABALIN	PREGABALIN	Direct Rx	d88925b8-9be6-d862-e053-2995a90a1612	2025-01-21	Adverse reactions	Exact identifier application applno (ANDA): 208677 application number: ANDA208677
PREGABALIN	PREGABALIN	Direct_Rx	91cf12b1-e1a6-dbc2-e053-2a95a90a8d5d	2025-01-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208677 application number: ANDA208677
Pregabalin	PREGABALIN	Preferred Pharmaceuticals, Inc.	8c3aedae-9745-4f63-ad64-a643f0245418	2025-01-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208677 application number: ANDA208677
Pregabalin	PREGABALIN	Advanced Rx of Tennessee, LLC	afc8c76e-9b21-7ddb-e053-2a95a90ad736	2024-12-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208677 application number: ANDA208677

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
55JG375S6M	PREGABALIN	148553-50-8	PREGABALIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
483438	pregabalin 100 MG Oral Capsule	PSN	f33a9245-8a54-4d1c-8fbd-e00194fa9c93	1
483440	pregabalin 150 MG Oral Capsule	PSN	f33a9245-8a54-4d1c-8fbd-e00194fa9c93	1
483446	pregabalin 200 MG Oral Capsule	PSN	f33a9245-8a54-4d1c-8fbd-e00194fa9c93	1
577127	pregabalin 225 MG Oral Capsule	PSN	f33a9245-8a54-4d1c-8fbd-e00194fa9c93	1
483442	pregabalin 25 MG Oral Capsule	PSN	f33a9245-8a54-4d1c-8fbd-e00194fa9c93	1
483444	pregabalin 300 MG Oral Capsule	PSN	f33a9245-8a54-4d1c-8fbd-e00194fa9c93	1
483448	pregabalin 50 MG Oral Capsule	PSN	f33a9245-8a54-4d1c-8fbd-e00194fa9c93	1
483450	pregabalin 75 MG Oral Capsule	PSN	f33a9245-8a54-4d1c-8fbd-e00194fa9c93	1
483438	pregabalin 100 MG Oral Capsule	SCD	f33a9245-8a54-4d1c-8fbd-e00194fa9c93	1
483440	pregabalin 150 MG Oral Capsule	SCD	f33a9245-8a54-4d1c-8fbd-e00194fa9c93	1
483446	pregabalin 200 MG Oral Capsule	SCD	f33a9245-8a54-4d1c-8fbd-e00194fa9c93	1
577127	pregabalin 225 MG Oral Capsule	SCD	f33a9245-8a54-4d1c-8fbd-e00194fa9c93	1
483442	pregabalin 25 MG Oral Capsule	SCD	f33a9245-8a54-4d1c-8fbd-e00194fa9c93	1
483444	pregabalin 300 MG Oral Capsule	SCD	f33a9245-8a54-4d1c-8fbd-e00194fa9c93	1
483448	pregabalin 50 MG Oral Capsule	SCD	f33a9245-8a54-4d1c-8fbd-e00194fa9c93	1
483450	pregabalin 75 MG Oral Capsule	SCD	f33a9245-8a54-4d1c-8fbd-e00194fa9c93	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
71610-331-53	71610033153	60 CAPSULE in 1 BOTTLE (71610-331-53)	60 capsule	2019-08-16	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Pregabalin - Aphena Pharma Solutions - Tennessee, LLC	Aphena Pharma Solutions - Tennessee, LLC	2019-08-27	HUMAN PRESCRIPTION DRUG LABEL	1